on 31 Dec 2024
Last Applicant/ Owned by
New York NY 10169
Serial Number
79382388 filed on 19th Jun 2023
Registration Number
7628824 registered on 31st Dec 2024
Correspondent Address
/Andrew N. Spivak/
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis in the field of the production of antibodies; scientific and technology services, namely, scientific research, testing and analysis in the field of antibodies and research and design services related thereto; industrial analysis servi Read More
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis in the field of the production of antibodies; scientific and technology services, namely, scientific research, testing and analysis in the field of antibodies and research and design services related thereto; industrial analysis services and industrial research services in the field of antibodies; industrial analysis and industrial research services in the field of chemistry
N/A
N/A
Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer
N/A
N/A
No 79382388
No Service Mark
No 26421
No
No
No
No
Yes
Yes
No
No
26.01.02 -
Plain single line circles
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
26.17.12 -
Chevrons and angles
Status Date | Action Taken |
---|---|
31st Dec 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
31st Dec 2024 | REGISTERED-PRINCIPAL REGISTER |
12th Nov 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
12th Nov 2024 | PUBLISHED FOR OPPOSITION |
23rd Oct 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
03rd Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
07th Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
06th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
06th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
11th Aug 2024 | REFUSAL PROCESSED BY IB |